Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Kate Anderton being referenced
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma
2018
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kate Anderton | 34 | 117 | 7 | 37 | 8 | 187 | |
| Yasuyuki Tokunaga | 31 | 136 | 1 | 33 | 7 | 217 | |
| Frédéric Canal | 29 | 145 | 44 | 9 | 242 | ||
| Emilie Le Roux | 33 | 150 | 4 | 35 | 5 | 203 | |
| Eunkyong Ko | 61 | 168 | 4 | 20 | 12 | 273 | |
| Pierre–Olivier Schischmanoff | 46 | 53 | 3 | 49 | 7 | 228 | |
| Joshua A. Ballard | 47 | 145 | 22 | 31 | 6 | 244 | |
| Víctor Amado | 47 | 133 | 3 | 81 | 11 | 264 | |
| Shunro Uchinokura | 55 | 139 | 7 | 149 | 8 | 296 | |
| Itaru Nishizuka | 60 | 88 | 3 | 33 | 7 | 197 | |
| Er‐Bin Zhang | 53 | 175 | 9 | 39 | 8 | 268 |
All Works
Loading papers...